US2012136020A1PendingUtilityA1
Treatment of effect of chemicals with their ultradilute stereoisomers
Est. expiryFeb 28, 2022(expired)· nominal 20-yr term from priority
Inventors:Reinhard Michael Kuzeff
A61P 39/00A61P 25/36A61K 31/485A61K 31/138
28
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating an effect of a chemical agent, which agent is characterized by one or more chiral centres, by administering a dilution or an ultra-high dilution or potentised preparation of a stereoisomer of said chemical agent.
Claims
exact text as granted — not AI-modified1 . A method of treating a human suffering from the effects of an optically active opiate, comprising the steps of: diluting a purified enantiomer of the opiate to provide a therapeutically effective dilution of said purified enantiomer; and administering said therapeutically effective dilution of said purified enantiomer to the human suffering from the effects of said optically active opiate.
Join the waitlist — get patent alerts
Track US2012136020A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.